FdaApplication
NDA 021402
Identifiers
- fda_app_no: NDA021402
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE INC |
| application_type | NDA |
| approval_date | 2002-07-24 |
Revenue by product
SYNTHROID
| Period | Revenue |
|---|---|
| Q4 2021 | $196.0M |
| Q3 2021 | $188.0M |
| Q2 2021 | $192.0M |
| Q1 2021 | $191.0M |
| Q4 2020 | $194.0M |
| Q3 2020 | $189.0M |
| Q2 2020 | $183.0M |
| Q1 2020 | $205.0M |
| Q4 2019 | $204.0M |
| Q3 2019 | $197.0M |
| Q2 2019 | $203.0M |
| Q1 2019 | $182.0M |
| Q4 2018 | $209.0M |
| Q3 2018 | $192.0M |
| Q2 2018 | $193.0M |
Revenue as this company reported it for this product. A combination product's amount is stated once, for the product, and never divided across its ingredients. A fourth quarter is the reported full year less nine months, since no filing states one.
Products (12)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
| SYNTHROID | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL |
12 products